Landry Cancer Biology Research Fellowships

In addition to the transformative programmatic support of the LCBC provided by the Landry Consortium gift, generous support will also be available to fund Landry Cancer Research Fellowships. Each spring, second-year GSAS PhD students will be invited to apply for one of five available fellowships. Fellows will receive tuition and stipend support for 18 months (G3 and G4 years), in addition to discretionary funds to promote professional development and attendance of international/national conferences in cancer biology and related topics. In addition to the innovative thesis research that these talented students will pursue, our steady state population of ten Landry Fellows and the alumni of this program will serve as ambassadors and role models for undergraduate students, inspiring the next generation of scientists to bring their own creativity and ambition to cancer biology research.

 

 

2016 cohort of Landry Cancer Biology Research Fellows:

Evavold headshot

Charlie Evavold
Immunology, Jonathan Kagan lab

Charlie Evavold grew up in Atlanta, GA. He graduated in May 2013 with a Bachelor of Science with highest honors from Emory University where he majored in both physics and chemistry. After graduation, he transitioned into biology research through an Oak Ridge Institute for Science and Education (ORISE) fellowship to work in the Q fever group at the Center for Disease Control and Prevention (CDC). After exposure to microbiology and infection biology, Charlie decided to pursue a PhD in Immunology to study complex signal processing in immune cells. Charlie joined the lab of Jon Kagan to study the tug-of-war between pro-survival signaling pathways and programs of cell death. He is currently investigating a somatic mutation found in the signaling adaptor MyD88 that causes aberrant toll-like receptor (TLR) signaling from endosomes that constitutes a pro-survival signal in certain B cell lymphomas. He is also investigating negative regulators of an inflammatory program of cell death, known as pyroptosis. His dissertation will focus on how pro-survival pathways and programs of cell death intersect to determine cancer and immune cell fate.

Eran HodisEran Hodis
Biophysics, Levi Garraway and Aviv Regev labs
 

Eran Hodis was born in Haifa, Israel and grew up in Framingham, Massachusetts. He pursued his interest in science and math as a University Scholar at Boston University, graduating in 2007 with a dual major Mathematics and in Biochemistry/Molecular Biology. Afterwards, he trained in computational biology at the Weizmann Institute of Science in Israel, earning an M.Sc. in 2010. When his mother was diagnosed with cancer, he dedicated himself to cancer research. At Harvard, Eran’s work in cancer genomics has contributed to our understanding of the genetic underpinnings of melanoma, the most lethal form of skin cancer. His current research seeks to better understand the disease by asking how mutations cooperate to make a melanoma. He co-teaches a highly-rated course on RNA-sequencing analysis in the Department of Stem Cell and Regenerative Biology: SCRB 152. Eran is a 2016 Paul & Daisy Soros Fellow and was listed among the Forbes ’30 Under 30’ in Science in 2015.

Manchester, HaleyHaley Manchester
Biological and Biomedical Sciences, Karen Cichowski lab
 

Haley Manchester was born in Providence, RI. In 2012, she graduated summa cum laude from Bates College with a B.S. in Biological Chemistry and minor in mathematics. During her time at Bates, she sang soprano in an all-female a capella group and studied traditional medicine in China and Vietnam for a semester. She first discovered her love of research after interning in a lab that developed small molecule inhibitors for Yersinia pestis, the bacteria behind the bubonic plague. After graduating from Bates, she worked as a research associate at the Dana-Farber Cancer Institute examining the role of a chromatin remodeling complex in cancer. She joined Dr. Karen Cichowski's lab in 2015 to study novel therapies for melanoma that target signaling pathways and important epigenetic regulators.

St Pierre, RooRoo St. Pierre
Chemical Biology, Cigall Kadoch lab
 

Roodolph St Pierre (Roo) was born and raised in Port au Prince, Haiti.  He graduated from the University of Massachusetts Boston with a Bachelor in Chemistry with Honors in 2011. During his undergraduate, Roo landed an internship at the Broad Institute in the lab of Dr. Stuart Schreiber where he gained a foundational introduction to structural biology. Following graduation, Roo transitioned to the lab of Dr. James Bradner at the Dana Farber Cancer Institute where he applied his structural biology toolkit to the art of cancer drug discovery. Now in the lab of Dr. Cigall Kadoch at Harvard, he is investigating the implication of SMARCE1 in the genesis of meningioma, which represents a third of all tumors that arise within the central nervous system. Beyond the lab, Roo serves as a mentor and advisory member to the Dana Farber/Harvard Cancer Center CURE program to expose a greater number of under-represented High School and College students to cancer research. On campus, Roo is the co-president of MBSH, a student group dedicated to fostering an environment conducive to the promotion of minority groups within academia.

Weiner, Katie

Katie Weiner
Molecules, Cells and Organisms, John Rinn lab

Catherine Weiner (Katie) was raised in Briarcliff Manor, New York. She graduated magna cum laude from the University of Rochester in 2014, with a major in Biochemistry and a minor in Mathematics. She is a member of Phi Beta Kappa. In addition to her rigorous academics, Katie was a four-year member of the Women’s Basketball team, earning Academic all-conference honors in the three years she was eligible and playing in the NCAA tournament twice. At Harvard, she currently works in the lab of John Rinn, where her work focuses on understanding the three dimensional organization of the genome using novel live-cell imaging techniques. She is particularly interested in the role noncoding RNAs play in mediating these interactions.

 

2015 cohort of Landry Cancer Biology Research Fellows:

Daniel Cohen
Chemical Biology, Loren Walensky lab
 

Daniel Thomas Cohen was born in Mountain View, California, and received his Bachelor of Science in Chemical Biology from UC Berkeley in 2012. Dan has been a creative and passionate scientist from the very beginning of his academic career. At Berkeley, he instructed a unique course for fellow undergrads called “Chemistry of Cooking.” His famously delicious lemon meringue cookie bars made for a series of fantastic biomolecular lessons on protein denaturation, lecithin-based emulsification, and the ability of fats to inhibit gluten agglomeration. Dan’s experience leading “Chemistry of Cooking” helped him discover a love for teaching, which he plans to pursue along with research. Here at Harvard, Dan’s work in Professor Loren Walensky’s lab combined synthetic chemistry, high-throughput screening, biochemistry, hydrogen-deuterium exchange mass spectrometry, and cancer cell biology approaches.

Molly DeCristo
Biomedical and Biological Sciences, Sandra McAllister lab
 

Molly DeCristo was born in Beverly, Massachusetts. As a youngster, she often wondered at the mystery of outer space and thought to one day study its vastness. As she grew older and saw the impact of cancer on the lives of her mother, aunt, and grandfather, Molly’s interests turned inward. She decided to spend her academic career understanding cancer instead. She attended UNC-Chapel Hill and received her Bachelor of Science in Biology, with Highest Honors and Distinction, in 2013. Since March 2014, Molly has worked in Professor Sandra McAllister’s lab, studying the systemic, host effects of chemotherapy in mouse models of triple negative and Her2+ breast cancer in hopes of understanding their implications in development of resistance to chemotherapy and eventual disease relapse. She also focuses on the impact of chemotherapy on bone marrow and bone marrow derived cell populations, examining the resulting effects on tumor progression and metastasis.

Jeff Gerold
Bioinformatics and Integrative Genomics, Martin Nowak lab
 

Jeff Gerold was born in Hoffman Estates, Illinois. In May 2013 he graduated magna cum laude from Washington University in St. Louis with a B.S. in Biomedical Engineering, with additional majors in Physics and Mathematics. Despite the heavy course load required for his triple major, Jeff was an active participant in campus life – he rowed crew (and was a Crew Academic All-American), tutored at a local charter school, and served as president of Wash U’s biomedical engineering honors society. His academic rigorous preparation has served him well at Harvard, where he works in Professor Martin Nowak’s lab. Jeff’s dissertation will focus on integrating cancer genomics and evolutionary modeling. Professor Nowak believes that Jeff’s work addresses a critical gap in the field: understanding evolutionary signatures hidden in large cancer datasets.

Yi-Jang Lin
Biological and Biomedical Sciences, Kevin Haigis lab
 

Yi-Jang Lin was born in New Taipei City, Taiwan. Yi-Jang is a star by all accounts. After being elected to Phi Beta Kappa, she graduated summa cum laude from Boston University in 2011 with Bachelors of Arts degrees in both Biology and French Language and Literature. A genuinely well-rounded student, Yi-Jang took courses in ballroom dance throughout her undergraduate career and spent a semester abroad in Grenoble. All this was in addition to rigorous coursework required for her specialization in cell biology, molecular biology, and genetics. After completing her studies at BU, Yi-Jang traveled to Taiwan to work as a research assistant in a lab focusing on translational research of new drug development for the treatment of hepatocellular carcinoma. She joined Professor Kevin Haigis’ lab at Harvard in 2014. Her project explores the possibility of a new therapeutic strategy (K-Ras acetylation) for certain lung cancers.

Amy Schade
Virology, Jim DeCaprio lab
 

Amy Schade was born in Grapevine, Texas. She graduated in 2013 from the University of North Texas, where she majored in Biology with a focus in Microbiology, and minored in both Chemistry and History. Amy was actually recruited to UNT as a debater and was active throughout her undergraduate career as both a college-level competitor and as a coach at a high school in her hometown – she was designated a National Debate Scholar Summa Cum Laude in 2012. At Harvard, she works in Professor James A. DeCaprio’s lab, determining the role of Cyclin D-CDK4/6 in the regulation of the DREAM complex. Outside the lab, Amy makes time for a commitment to increasing diversity in science. She has served as a mentor for underrepresented minority undergrads in Harvard’s longstanding SHURP program and is engaged in Dana-Farber’s CURE program, which helps guide underrepresented minority undergrads and high schoolers in evaluating the primary scientific literature.